Preston F E, Ward J D, Marcola B H, Porter N R, Timperley W R, O'Malley B C
Lancet. 1978 Feb 4;1(8058):238-40. doi: 10.1016/s0140-6736(78)90483-x.
beta-Thromboglobulin levels and platelet-aggregate ratios were determined in blood-samples from healthy control subjects and from diabetic patients with and without microangiopathic complications. Patients with diabetic microangiopathy had significantly elevated beta-thromboglobulin levels and also reversible platelet aggregates. In nine newly treated diabetics blood-glucose control was associated with a significant fall in plasma beta-thromboglobulin. Since beta-thromboglobulin is a platelet-specific protein the results indicate that diabetic microangiopathy is associated with evidence of platelet activation and that this may be influenced by the degree of biochemical control.
在健康对照受试者以及患有和未患有微血管病变并发症的糖尿病患者的血液样本中,测定了β-血小板球蛋白水平和血小板聚集率。患有糖尿病微血管病变的患者β-血小板球蛋白水平显著升高,并且存在可逆性血小板聚集。在9名新接受治疗的糖尿病患者中,血糖控制与血浆β-血小板球蛋白显著下降相关。由于β-血小板球蛋白是一种血小板特异性蛋白,这些结果表明糖尿病微血管病变与血小板活化的证据相关,并且这可能受生化控制程度的影响。